Induction of posterior vitreous detachment (PVD) by non-enzymatic reagents targeting vitreous collagen liquefaction as well as vitreoretinal adhesion

Induction of posterior vitreous detachment (PVD) by pharmacologic vitreolysis has been largely attempted through the use of enzymatic reagents. Ocriplasmin has been the only FDA-approved clinical reagent so far. Several adverse effects of ocriplasmin have emerged, however, and the search for alterna...

Descripción completa

Detalles Bibliográficos
Autores principales: Santra, Mithun, Sharma, Maryada, Katoch, Deeksha, Jain, Sahil, Saikia, Uma Nahar, Dogra, Mangat R., Luthra-Guptasarma, Manni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237681/
https://www.ncbi.nlm.nih.gov/pubmed/32427865
http://dx.doi.org/10.1038/s41598-020-64931-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237681/
https://www.ncbi.nlm.nih.gov/pubmed/32427865
http://dx.doi.org/10.1038/s41598-020-64931-3

Ejemplares similares